| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/13/2015 | US8933031 Polypeptide inhibiting angiogenesis and application thereof |
| 01/13/2015 | US8933030 Treatments for gastrointestinal disorders |
| 01/13/2015 | US8933029 Antimicrobial and anti-inflammatory peptides |
| 01/13/2015 | US8933028 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue |
| 01/13/2015 | US8933027 Method of treating a disease or condition characterised by aberrant epithelial cell proliferation |
| 01/13/2015 | US8933026 Derivatisation of erythropoietin (EPO) |
| 01/13/2015 | US8933025 Agent for suppressing postprandial elevation of blood insulin concentration |
| 01/13/2015 | US8933024 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| 01/13/2015 | US8933023 Rapid acting injectable insulin compositions |
| 01/13/2015 | US8933022 Methods and compositions for the treatment and prevention Hypoglycemia and related disorders |
| 01/13/2015 | US8933021 Insulin derivative |
| 01/13/2015 | US8933019 Antiviral cell-penetrating peptides |
| 01/13/2015 | US8933018 Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 01/13/2015 | US8933017 CD44V6 peptides as inhibitors of bacterial infections |
| 01/13/2015 | US8933015 Macrocyclic inhibitors of flaviviridae viruses |
| 01/13/2015 | US8933014 HJURP peptides and vaccines including the same |
| 01/13/2015 | US8933013 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 01/13/2015 | US8933012 Glycopeptide antibiotic derivative |
| 01/13/2015 | US8933011 Treatment of preterm labor with toll-like receptor 9 antagonists |
| 01/13/2015 | US8932829 Recombinant alpha-fetoprotein and compositions thereof |
| 01/13/2015 | US8932826 Method for simultaneously determining multiple coagulation proteases |
| 01/13/2015 | US8932821 NOGO receptor binding protein |
| 01/13/2015 | US8932814 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes |
| 01/13/2015 | US8932651 Functional food product comprising heat shock protein or a hydrolysate thereof |
| 01/13/2015 | US8932642 Treating prostate, ovarian, or breast cancer with a whole, leech saliva extract |
| 01/13/2015 | US8932640 Process for preparing a particle comprising a biological molecule and a carrier polymer |
| 01/13/2015 | US8932617 Methods for treating or preventing restenosis and other vascular proliferative disorders |
| 01/13/2015 | US8932609 Flagellin related polypeptides and uses thereof |
| 01/13/2015 | US8932596 Method of treating eosinophilic esophagitis |
| 01/13/2015 | US8932589 Methods and compositions using Kloto-FGF23 fusion polypeptides |
| 01/13/2015 | US8932587 Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase |
| 01/13/2015 | US8932586 Modified forms of Pseudomonas exotoxin A |
| 01/13/2015 | US8932579 Biological effects of compositions comprising rosmarinic acid |
| 01/13/2015 | US8932578 Cell and enzyme compositions for modulating ale acids, cholesterol and triglycerides |
| 01/13/2015 | US8932575 Compositions and methods for inducing migration by dendritic cells and an immune response |
| 01/13/2015 | US8932574 Stable liquid interferon beta formulations |
| 01/13/2015 | US8932559 Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes |
| 01/13/2015 | CA2612151C Agents and methods based on the use of the eda domain of fibronectin |
| 01/13/2015 | CA2580426C Deglycosylated and desialidated long pentraxin ptx3 |
| 01/13/2015 | CA2579726C Macrocyclic modulators of the ghrelin receptor |
| 01/13/2015 | CA2521402C Pectate lyases, nucleic acids encoding them and methods for making and using them |
| 01/13/2015 | CA2498777C Non-sequence complementary antiviral oligonucleotides |
| 01/08/2015 | WO2015003167A1 Thermally stable ph20 hyaluronidase variants and uses thereof |
| 01/08/2015 | WO2015003128A1 Reducing adverse side effects of a compound by a neurotoxin |
| 01/08/2015 | WO2015002903A1 Method for treating cognitive dysfunction |
| 01/08/2015 | WO2015002611A1 Compositions and methods for inhibiting thrombogenesis |
| 01/08/2015 | WO2015002604A1 Secretagogues derived from oxalobacter formigenes |
| 01/08/2015 | WO2015002588A1 Secretagogues derived from oxalobacter formigenes |
| 01/08/2015 | WO2015002537A1 Amino acid composition for use in the treatment of a pdd |
| 01/08/2015 | WO2015001573A1 Synergistic compositions |
| 01/08/2015 | WO2015001361A1 Immunotherapy |
| 01/08/2015 | WO2015001352A1 Novel regenerative therapy |
| 01/08/2015 | WO2015001163A2 Lipid nanoparticles for healing wounds |
| 01/08/2015 | WO2015001160A1 Lipid nanoparticle of polymyxin |
| 01/08/2015 | WO2015001092A1 Mammalian milk osteopontin for enhancing immune responsiveness |
| 01/08/2015 | WO2015001082A1 Novel alternative splice transcripts for mhc class i related chain alpha (mica) and uses thereof |
| 01/08/2015 | WO2015001053A1 Methods for the screening of substances that may be useful for the prevention and treatment of infections by enterobacteriaceae family |
| 01/08/2015 | WO2015001015A1 Actively transported and protease-resistant peptides as bbb shuttles and shuttle-cargo constructs |
| 01/08/2015 | WO2015000988A1 C1q as a therapeutic agent of allergy and/or asthma |
| 01/08/2015 | WO2015000986A1 Composition involved in regulating energy cycle, inflammation and insulin resistance dysfunctions, and use thereof particularly in cardiometabolic diseases |
| 01/08/2015 | WO2015000921A1 Ptgds pathway activators and use in pathologies characterized by altered myelination in the cns |
| 01/08/2015 | WO2015000871A1 Protective solution for preventing or reducing reperfusion injury of the brain and the whole body |
| 01/08/2015 | WO2015000694A1 Lactoferrin-osteopontin-iron complex |
| 01/08/2015 | WO2015000624A1 Method for producing antibodies using ovine b-cells and uses thereof |
| 01/08/2015 | WO2015000585A1 Muteins of cytokines of the gamma-chain receptor family conjugated to a non-protein group |
| 01/08/2015 | WO2015000413A1 Long-acting blood sugar decreasing fusion protein |
| 01/08/2015 | WO2015000371A1 He pula peptide formulation |
| 01/08/2015 | WO2015000181A1 Novel recombinant fusion protein, preparation method therefor and use thereof |
| 01/08/2015 | WO2015000053A1 Enzyme formulation for use as food supplement |
| 01/08/2015 | WO2015000022A1 Treatment and prevention of mastitis |
| 01/08/2015 | WO2015000014A1 Diagnosis and treatment of autoimmune diseases |
| 01/08/2015 | US20150011864 Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease |
| 01/08/2015 | US20150011736 Binding molecule conjugates |
| 01/08/2015 | US20150011732 Polymer conjugates of interferon beta-1a and uses |
| 01/08/2015 | US20150011577 Oxymorphone controlled release formulations |
| 01/08/2015 | US20150011563 Treating Sexual Desire Disorders with Flibanserin |
| 01/08/2015 | US20150011502 Methods and compositions to treat myocardial conditions |
| 01/08/2015 | US20150011481 Methods for Treating HCV |
| 01/08/2015 | US20150011480 Method of treating blurred vision and other conditions of the eye with cyclosporin compositions |
| 01/08/2015 | US20150011479 Alpha1 proteinase inhibitor peptides methods and use |
| 01/08/2015 | US20150011478 Cmv gene products promote cancer stem cell growth |
| 01/08/2015 | US20150011475 Method for screening an agent being useful for the treatment of dry eye and /or corneal and conjunctival lesion and a pharmaceutical composition obtained by the method |
| 01/08/2015 | US20150011474 Polypeptides binding to human complement c5 |
| 01/08/2015 | US20150011473 Stabilized pth formulation |
| 01/08/2015 | US20150011472 Malleable multi-component implants and materials therefor |
| 01/08/2015 | US20150011471 Regeneration of islet beta cells by hsp60 derived peptides |
| 01/08/2015 | US20150011468 Uses of casein compositions |
| 01/08/2015 | US20150011463 Agent for preventing or ameliorating vascular endothelial malfunction |
| 01/08/2015 | US20150011461 Heteroaryl pyridone and aza-pyridone amide compounds |
| 01/08/2015 | US20150011460 Alpha 1-proteinase inhibitor for delaying the onset or progression of pulmonary exacerbations |
| 01/08/2015 | US20150010946 Polynucleotides encoding zcytor17 ligand antibodies |
| 01/08/2015 | US20150010654 Methods and Compositions for Treating Mucosal Tissue Disorders |
| 01/08/2015 | US20150010647 Methods for Identifying Fragile Histidine Triad (FHIT) Interaction and Uses Thereof |
| 01/08/2015 | US20150010617 Inhalable liquid formulations of dnase i |
| 01/08/2015 | US20150010616 Biocompatible Particles and Method for Preparing Same |
| 01/08/2015 | US20150010613 Compositions and methods for cancer immunotherapy |
| 01/08/2015 | US20150010607 Liquefaction of bone matrix |
| 01/08/2015 | US20150010606 Intra-articular injection and implant attachment of molecule consisting of lubricin and extracellular superoxide dismutase or hyaluronic acid and extracellular superoxide dismutase |
| 01/08/2015 | US20150010595 Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule |
| 01/08/2015 | US20150010587 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |